Trial Profile
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Adenocarcinoma; Colon cancer; Rectal cancer
- Focus Therapeutic Use
- 03 Apr 2013 New trial record